Eculizumab for atypical hemolytic-uremic syndrome. How long should we maintain it?
Eculizumab for atypical hemolytic-uremic syndrome. How long should we maintain it?
Nefrologia. 2019 Feb 21;:
Authors: Naranjo Muñoz J, Garcia Garcia-Doncel A, Montero Escobar ME, Villanego Fernandez F, Millán Ortega I, Ceballos Guerrero M
PMID: 30798995 [PubMed - as supplied by publisher]
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
More News: Hemolytic Uremic Syndrome (HUS) | Urology & Nephrology